| |
|
|
|
Aldeyra Therapeutics Inc.  
|
|
6.84 0.18 (0.03%) |
06-18 16:00 |
|
Open: |
6.71 |
Pre close: |
6.66 |
Target:
|
8.40
|
|
High: |
7.08 |
Low: |
6.75 |
Resistance:
|
7.19
7.71
|
|
Volume: |
294,110 |
Market Cap: |
188M |
Support:
|
6.34
5.28
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
6.68
 |
MACD |
MACD(12,26):
|
-0.25 |
|
MA(20): |
6.92  |
Signal(12,26,9): |
-0.28 |
|
MA(100): |
7.94 |
Stochastic Oscillator |
%K(14,3):
|
35.33 |
|
MA(250): |
8.65 |
%D(3): |
26.90 |
|
Average Volume(K) |
3-Month: |
64098
|
52-Week |
High:
|
16.70 |
|
10-Days: |
21316 |
Low: |
6.34 |
|
RSI |
RSI(14):
|
44.00 |
Change(%): |
-20.5 |
|
Financials, Statistics and Valuation |
|
EPS |
-1.800 |
Return on Equity (ttm) |
-82.9 |
Shares Out. (M) |
27.49 |
|
EPS Est. Current Year |
-1.470 |
Return on Assets (ttm) |
-73.6 |
Shares Float (M) |
26.78 |
|
EPS Est. Next Year |
-1.740 |
PEG Ratio |
0.00 |
% Held by Insiders |
0.00 |
|
EPS Est. Next Quarter |
-0.370 |
Qtrly Rev. Growth |
0.0 |
% Held by Institutions |
79.20 |
|
Forward EPS |
-2.372 |
Gross Profit (p.s.) |
0.000 |
Shares Short (K) |
0 |
|
Book Value (p.s.) |
2.350 |
EBITDA (p.s.) |
0.000 |
P/E |
-3.80 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
2.91 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-34.53 |
P/S |
0.00 |
|
Operating Margin |
0.00 |
Levered Free Cash Flow
(M) |
-57.55 |
P/CF |
-5.45 |
|
|
|
|
|
|
